Ursodiol and Obliterative bronchiolitis - a phase IV clinical study of FDA data

Summary:

Obliterative bronchiolitis is reported as a side effect among people who take Ursodiol (ursodiol), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Acyclovir, and have Graft versus host disease.

The phase IV clinical study analyzes which people have Obliterative bronchiolitis when taking Ursodiol. It is created by eHealthMe based on reports of 18,820 people who have side effects when taking Ursodiol from the FDA, and is updated regularly.

What is Ursodiol?

Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.

What is Obliterative bronchiolitis?

Obliterative bronchiolitis (bronchiolar inflammation) is found to be associated with 163 drugs and 489 conditions by eHealthMe. Check the latest studies of Obliterative bronchiolitis.

On Aug, 08, 2026

18,820 people reported to have side effects when taking Ursodiol.
Among them, 13 people (0.07%) have Obliterative bronchiolitis.

Could Ursodiol cause Obliterative bronchiolitis?

Among these 13 people:

How long have people been on Ursodiol when they have Obliterative bronchiolitis? *

What is the gender of people who have Obliterative bronchiolitis when taking Ursodiol? *

female: 50 %
male: 50 %

What is the age of people who have Obliterative bronchiolitis when taking Ursodiol? *

What are other drugs people take besides Ursodiol? *

What are other side effects people have besides Obliterative bronchiolitis? *

Hepatic Function Abnormal: 4 people, 30.77%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 4 people, 30.77%
High Blood Pressure: 3 people, 23.08%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 3 people, 23.08%
Graft Versus Host Disease In Intestine (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body and damages intestinal mucosal membrane): 3 people, 23.08%
Gastritis (inflammation of stomach): 3 people, 23.08%
Fever: 3 people, 23.08%
Septic Shock (shock due to blood infection): 3 people, 23.08%
Engraft Failure: 3 people, 23.08%
Hypertriglyceridaemia (excess of triglycerides in the blood): 3 people, 23.08%

What are the existing conditions these people have? *

Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 5 people, 38.46%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 30.77%
Pneumonia: 3 people, 23.08%
Capillary Leak Syndrome (capillary leaks plasma): 3 people, 23.08%
Bone Marrow Conditioning Regimen: 3 people, 23.08%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 23.08%
Secondary Immunodeficiency (lack of immunity due to some disease): 2 people, 15.38%
White Blood Cell Count Increased: 1 person, 7.69%
Insomnia (sleeplessness): 1 person, 7.69%
Hodgkin's Lymphoma (cancer originating from white blood cells): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ursodiol and have Obliterative bronchiolitis?

- Check whether Obliterative bronchiolitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ursodiol:

Ursodiol (19,061 reports)

Browse all side effects of Ursodiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Obliterative bronchiolitis:

Obliterative bronchiolitis (163 drugs)

Browse all the conditions that are associated with Obliterative bronchiolitis:

Obliterative bronchiolitis (489 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol (the active ingredients of Ursodiol) and Ursodiol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.